35 participants
An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-13
- Start Date:
- 2017-10-30
- Completion:
- 2035-06-30
Conditions
- Crohn's Disease
Interventions
- DRUG
No Results Yet